why choose us

First received: June 12, 2023

Clinical Trial: A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Atopic Dermatitis

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, 52 Week Study to Evaluate the Efficacy and Safety of LY3454738 in the Treatment of Adult Patients With Moderate-to-Severe Atopi

Brief Summary: The main purpose of this study is to describe the efficacy and safety of LY3454738 in adult participants with moderate-to-severe atopic dermatitis (AD).

Read more